Smithers - Pharmaceutical Development Services

Smithers Pharmaceutical Development Services assists in the development of new medicines by providing bioanalytical services for all phases of drug development from discovery through approval and post-market surveillance. We work with our customers to develop new methods, validate existing methods, as well as perform the assays necessary to analyze samples from patients on more than 100 clinical trials currently in different phases of the FDA-regulated drug approval process. Our expert scientists perform large molecule bioanalysis, assay development, validation, and sample analysis at our GLP, GCP, and CLIA-compliant laboratories

Contract research,glp,clia,method development,validation,sample analysis,large molecule ligand-binding assays,gcp,bioanalysis,cell and gene therapy,multiplex immunoassays,molecular biology,qpcr,ddpcr,immunogenicity (ada) assays,and biomarkers

Smithers - pharmaceutical development services operates in the Pharmaceutical manufacturing industry.

Smithers - pharmaceutical development services's revenue is 11m - 100m

Smithers - pharmaceutical development services has 11 - 50 employees.